The two most-prescribed weight loss medications in America are semaglutide and tirzepatide. Patients ask us daily which one is "better." The honest answer: it depends on what you're solving for. Here's the plain-English comparison.
The one-sentence version
Semaglutide (Ozempic, Wegovy) activates one hormone pathway (GLP-1). Tirzepatide activates two (GLP-1 and GIP). Because tirzepatide hits two receptors, it typically produces greater weight loss — but semaglutide has a longer safety track record and is often the smarter starting point.
How each medication works
Both drugs mimic natural gut hormones that regulate appetite. When you eat, your intestines release GLP-1, which signals your brain that you're full, slows how quickly food leaves your stomach, and improves how your body handles insulin.
Semaglutide is a pure GLP-1 receptor agonist — it activates the GLP-1 receptor and nothing else.
Tirzepatide is a dual agonist: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is another gut hormone that influences insulin sensitivity and, when combined with GLP-1 activation, appears to amplify the appetite-reduction effect.
What the clinical trials show
The best head-to-head data comes from separate large pivotal trials:
- Semaglutide (STEP-1 trial): Average 14.9% body weight loss over 68 weeks at the maximum 2.4mg dose.
- Tirzepatide (SURMOUNT-1 trial): Average 15% weight loss at the 5mg dose, 19.5% at 10mg, and 22.5% at 15mg — all over 72 weeks.
Tirzepatide's higher-dose arm produced the largest sustained weight loss ever documented for a non-surgical intervention. But those trial averages don't tell you what you will experience — individual response varies significantly.
Our patients on semaglutide have reported losses from 15 to 50+ lbs. Our tirzepatide patients tend to hit the higher end of that range faster — but with more up-front side effect management during the dose ramp.
Dosing schedules — where they differ
Both are once-weekly injections that titrate up over months.
Semaglutide starts at 0.25mg and steps up every 4 weeks through 0.5mg, 1.0mg, 1.7mg, and 2.4mg (the maximum for weight loss). Most patients settle at 1.0–1.7mg.
Tirzepatide starts at 2.5mg and steps up every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Most patients settle at 7.5–10mg.
Neither dose progression should be rushed. In our clinic we frequently hold patients at a lower dose if they're getting good results — the goal is sustainable weight loss, not maximizing the medication.
Side effects — practically identical
The side effect profiles overlap almost entirely: nausea, reduced appetite, occasional constipation or diarrhea, transient fatigue during dose steps. GI symptoms are most common in the first weeks of a new dose and typically fade as your body adjusts.
Tirzepatide's higher potency can produce slightly more intense side effects during titration, but with weekly physician check-ins we manage that by slowing the ramp when needed. See our side effects guide for how we handle each symptom in clinic.
Cost - depends on dosage needed
Both medications require a titration schedule as you increase your dosage the price of Tirzepatide increases at a faster rate than Semaglutide. At higher doses the price of Tirzepatide can be 3x what Semaglutide would cost. We offer a price match guarantee if you find a lower legitimate quote elsewhere.
How we decide which to prescribe
There's no universal right answer. Our decision factors:
- Starting BMI and weight loss goal. Patients with more to lose often benefit from tirzepatide's higher ceiling.
- Prior GLP-1 experience. If semaglutide plateaued, tirzepatide is a logical next step. If a patient tolerated one poorly, we may not try the other in the same class.
- Insurance coverage. If one is covered and the other isn't, that's a big practical factor.
- Comorbidities. Certain conditions affect our choice — we assess this during the health-history review.
Most patients starting from scratch benefit from starting with semaglutide, seeing how their body responds, and moving to tirzepatide later if the results plateau or their goals change.
The bottom line
If you want the medication with the largest weight-loss ceiling and are prepared to manage a slightly more intense titration: tirzepatide.
If you want the more established medication with a longer real-world safety track record and slightly gentler dose ramp: semaglutide.
If you want a physician to look at your specific situation and recommend the right one for you: book a free consultation. We do this every day.
